TrialNature medicine2022

In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.

Irina Gurevich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.